Clinical Trial Update: A Study of The Effect of Aleglitazar on Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the effect of Aleglitazar on insulin sensitivity in patients with Type 2 diabetes mellitus inadequately controlled with metformin. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Aleglitazar (Aleglitazar)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus Type 2 | Phase 2 | Status: COMPLETED